β-blockers in Heart Failure

The endpoint of all-cause mortality or non-fatal MI was significantly reduced (14% vs. 20%) with carvedilol.38 Taking into account these results and those of other trials with the beta-adrenergic blockers, a beta-adrenergic blocker is recommended in patients post-MI, regardless of LVEF. ................
................